Why the study?
Atypical antipsychotics are increasingly used in the NICU for neonatal delirium despite potential adverse effects, and most reported pediatric cases of neuroleptic malignant syndrome have been in older children.
Answers are grounded in this paper and cite their sources.
Atypical antipsychotics used for neonatal delirium can cause rare but life-threatening neuroleptic malignant syndrome, which may present with atypical features such as myocardial infarction in infants.
In recent times, atypical antipsychotics are increasingly being used in the neonatal intensive care unit (NICU) for the management of neonatal delirium. As the recognition of delirium in NICU infants increases, caution should be exercised with use of antipsychotics for management, given associated adverse effects. Neuroleptic malignant syndrome (NMS) is a rare adverse drug reaction associated with exposure to antipsychotics and other antidopaminergic medications. Most reported cases of NMS in pediatric patients have been in older children on antipsychotic medications. We present a case of a 10-month-old former preterm infant who developed clinical signs suggestive of NMS after exposure to olanzapine for treatment of delirium. Our case report details the clinical course of this infant, delves into the condition, and outlines some useful lessons for the clinician in the identification and management of this rare but life-threatening adverse effect.
No takes yet. Share an insight, caveat, or question.
Akuamoah-Boateng et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: